Phreesia (PHR)
NYSE:PHR
Want to see PHR full AI Analyst Report?
PHR Stock Chart & Stats
$9.17
$0.87(3.22%)
At close: 4:00 PM EST
$9.17
$0.87(3.22%)
Day’s Range― - ―
52-Week Range$7.77 - $32.76
Previous CloseN/A
Volume173.69K
Average Volume (3M)1.58M
Market Cap
$551.36M
Enterprise Value$595.79M
Total Cash (Recent Filing)$74.71M
Total Debt (Recent Filing)$92.56M
Price to Earnings (P/E)60.1
Beta1.02
Next Earnings
Sep 09, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding61,811,890
10 Day Avg. Volume1,095,554
30 Day Avg. Volume1,583,503
Financial Highlights & Ratios
PEG Ratio-3.35
Price to Book (P/B)2.38
Price to Sales (P/S)1.67
P/FCF Ratio11.85
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue1.20
Enterprise Value/Gross Profit1.83
Enterprise Value/Ebitda14.04
Forecast
1Y Price Target
$14.00Price Target Upside52.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
EPS Forecast (FY)0.4
Revenue Forecast (FY)$515.19M
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationSustained FCF and recent 19% FCF growth show the business converts earnings into cash efficiently. High cash conversion (FCF ~86% of net income) gives durable optionality to fund operations, repay debt, invest in product development, or support inorganic growth without frequent capital raises.
Profitability Inflection And EBITDA ImprovementThree consecutive positive net-income quarters and materially higher adjusted EBITDA reflect structural operating progress and cost discipline. If sustained, this improves internal funding capacity, reduces reliance on external financing, and validates the scalability of the recurring-revenue model over coming quarters.
Recurring Client Base Growth And Higher Revenue Per ClientNet adds and rising revenue per client indicate healthy retention and upsell within a recurring subscription/payment mix. Expanding AHSC and per-client monetization underpin predictable revenue streams and provide a durable runway for cross-sell of modules and payments services.
Bears Say
Thin Operating MarginsOperating profitability remains very thin despite positive net income, leaving limited buffer for revenue weakness or investment. Small margin levels make earnings sensitive to cost re-acceleration or lower utilization, constraining the firm's ability to absorb shocks while funding growth from operations.
Sequential Subscription Revenue DeclineSubscription revenue is core recurring cash flow; a sequential decline and deliberate pricing moderation signal pressure on baseline recurring revenue and future monetization. If persistent, this weakens the predictability of cash flow and limits upside from upsells and lifetime-value improvements.
Higher Receivables Concentration And Contingent Guarantor ExposureExpanded securitization and higher concentration limits increase credit concentration and default exposure in the receivables pool, while co-guarantor status creates contingent liabilities on Phreesia's balance sheet. These structural funding risks could amplify losses and constrain covenants or liquidity under stress.
Phreesia News
PHR FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest stock price was $7.77 and its highest was $32.76 in the past 12 months.
What is Phreesia’s market cap?
Phreesia’s market cap is $551.36M.
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Sep 09, 2026 which is in 77 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on May 27, 2026. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.011 by $0.039.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is 0.09.
How many shares outstanding does Phreesia have?
Phreesia has 61,811,890 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of $0.05 in its last earnings report, beating expectations of $0.011. Following the earnings report the stock price went up 3.505%.
Which hedge fund is a major shareholder of Phreesia?
Currently, no hedge funds are holding shares in PHR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Phreesia Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.00 (52.67% Upside)
$14.00 (52.67% Upside)
Blogger Sentiment
Neutral
PHR Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $10.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 4.1%
Last 30 Days ▼ 4.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.96%
12-Months-Change
Fundamentals
Return on Equity
2.79%
Trailing 12-Months
Asset Growth
66.37%
Trailing 12-Months
Company Description
Phreesia
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
PHR Company Deck
PHR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple clear operating and financial positives: solid top-line growth (+13% YoY), strong adjusted EBITDA improvement (+~46% YoY) and a return to net income, improved operating and free cash flow, enhanced liquidity via refinancing and a larger securitization facility for Access One, and maintained full-year guidance. Headwinds included a sequential decline in subscription revenue, higher variability and lower-than-expected client commitments in Network Solutions for the back half of the year, and some dependence of Payment Solutions growth on the recent Access One acquisition. On balance, the positive operational and financial momentum, maintaining guidance, and strategic financing and product initiatives outweigh the listed challenges.View all PHR earnings summariesPHR Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
PHR Stock 12 Month Forecast
Average Price Target
$14.00
▲(52.67% Upside)
Technical Analysis
Ownership Overview
20.45% Insiders
22.24% Mutual Funds
35.52% Other Institutional Investors
10.23% Public Companies and
Individual Investors